Header Logo

Connection

MANDEEP BAJAJ to Animals

Back to Details
This is a "connection" page, showing publications MANDEEP BAJAJ has written about Animals.
MANDEEP BAJAJ
Connection Strength
0.298
Animals
  1. PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins. Cardiovasc Drugs Ther. 2014 Oct; 28(5):447-57.
    View in: PubMed
    Score: 0.027
  2. The regulation of muscle protein turnover in diabetes. Int J Biochem Cell Biol. 2013 Oct; 45(10):2239-44.
    View in: PubMed
    Score: 0.025
  3. Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation. J Hepatol. 2013 Mar; 58(3):634-5.
    View in: PubMed
    Score: 0.024
  4. Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012 Dec; 10(6):387-90.
    View in: PubMed
    Score: 0.023
  5. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011 Dec; 54(12):3093-100.
    View in: PubMed
    Score: 0.022
  6. Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus. Expert Opin Pharmacother. 2006 Jun; 7(8):1055-64.
    View in: PubMed
    Score: 0.015
  7. SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes. Cardiovasc Drugs Ther. 2022 12; 36(6):1091-1108.
    View in: PubMed
    Score: 0.011
  8. Cysticercosis in ophthalmology. Surv Ophthalmol. 2022 Mar-Apr; 67(2):544-569.
    View in: PubMed
    Score: 0.011
  9. miR-30a targets gene networks that promote browning of human and mouse adipocytes. Am J Physiol Endocrinol Metab. 2020 10 01; 319(4):E667-E677.
    View in: PubMed
    Score: 0.010
  10. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy. Cardiovasc Drugs Ther. 2020 12; 34(6):835-848.
    View in: PubMed
    Score: 0.010
  11. DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome. Basic Res Cardiol. 2019 08 06; 114(5):35.
    View in: PubMed
    Score: 0.009
  12. Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation. Cardiovasc Drugs Ther. 2018 12; 32(6):553-558.
    View in: PubMed
    Score: 0.009
  13. miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity. Diabetes. 2018 12; 67(12):2541-2553.
    View in: PubMed
    Score: 0.009
  14. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes. Cardiovasc Drugs Ther. 2018 04; 32(2):135-145.
    View in: PubMed
    Score: 0.009
  15. Superior oblique muscle cysticercosis: importance of long-term assessment by a single observer. Can J Ophthalmol. 2018 10; 53(5):e193-e195.
    View in: PubMed
    Score: 0.009
  16. Adiponectin is required for maintaining normal body temperature in a cold environment. BMC Physiol. 2017 Oct 23; 17(1):8.
    View in: PubMed
    Score: 0.008
  17. Cysticercosis of the eyelid. BMJ Case Rep. 2017 Aug 29; 2017.
    View in: PubMed
    Score: 0.008
  18. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor. Cardiovasc Drugs Ther. 2017 Apr; 31(2):119-132.
    View in: PubMed
    Score: 0.008
  19. Aleglitazar, a dual peroxisome proliferator-activated receptor-a and -? agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia. Diab Vasc Dis Res. 2017 03; 14(2):152-162.
    View in: PubMed
    Score: 0.008
  20. Aleglitazar, a Balanced Dual PPARa and -? Agonist, Protects the Heart Against Ischemia-Reperfusion Injury. Cardiovasc Drugs Ther. 2016 Apr; 30(2):129-41.
    View in: PubMed
    Score: 0.007
  21. Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes. Mol Endocrinol. 2015 Sep; 29(9):1320-33.
    View in: PubMed
    Score: 0.007
  22. MicroRNA-dependent cross-talk between VEGF and HIF1a in the diabetic retina. Cell Signal. 2013 Dec; 25(12):2840-7.
    View in: PubMed
    Score: 0.006
  23. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart. Basic Res Cardiol. 2013 May; 108(3):352.
    View in: PubMed
    Score: 0.006
  24. Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus. Cardiovasc Drugs Ther. 2012 Dec; 26(6):445-56.
    View in: PubMed
    Score: 0.006
  25. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013 Jan 01; 304(1):H131-41.
    View in: PubMed
    Score: 0.006
  26. Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther. 2008 11; 16(11):1805-12.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.